Back to search
FDAFDA · Food and drugs·Recall number Z-1284-2023

G7 Acetabular System, Dual Mobility Acetabular Liner, 40 mm, Size D, Model Number 110024462

Published March 29, 2023 · Recall initiated: February 6, 2023

Summary

FDA records medical device Class II recall Z-1284-2023, published March 29, 2023 and initiated February 6, 2023. Recalling firm: Biomet, Inc.; Status: Ongoing; Reported quantity: 12 units; Lot: UDI: (01)00880304703506(17)321128(10)65731960; Lot Number: 65731960. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The outer package labeling and product etch are a 40 mm Size D liner, however, the implant is a 38 mm Size C liner.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Biomet, Inc.
Distributor
US Distribution to states of: AZ, FL, GA, MI, NE, and TX.
Lot
UDI: (01)00880304703506(17)321128(10)65731960; Lot Number: 65731960
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was G7 Acetabular System, Dual Mobility Acetabular Liner, 40 mm, Size D, Model Number 110024462 recalled?

Yes. FDA published recall Z-1284-2023 on March 29, 2023. Reported hazard: The outer package labeling and product etch are a 40 mm Size D liner, however, the implant is a 38 mm Size C liner.

What should I do if I have this product?

Voluntary: Firm initiated · Letter